Cosmos Health Inc. (COSM)
NASDAQ: COSM · Real-Time Price · USD
0.462
-0.034 (-6.94%)
At close: Dec 5, 2025, 4:00 PM EST
0.473
+0.011 (2.40%)
After-hours: Dec 5, 2025, 7:46 PM EST

Company Description

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus.

The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names.

It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin).

In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand.

It serves wholesalers and retail healthcare providers. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

Cosmos Health Inc.
Cosmos Health logo
Country United States
Founded 2009
IPO Date Dec 13, 2013
Industry Medical Distribution
Sector Healthcare
Employees 149
CEO Grigorios Siokas

Contact Details

Address:
141 West Jackson Boulevard, Suite 4236
Chicago, Illinois 60604
United States
Phone 312 536 3102
Website cosmoshealthinc.com

Stock Details

Ticker Symbol COSM
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001474167
CUSIP Number 221413206
ISIN Number US2214133058
Employer ID 27-0611758
SIC Code 5122

Key Executives

Name Position
Grigorios Siokas Chairman and Chief Executive Officer
Georgios Terzis Chief Financial Officer
Nikolaos Bardakis Chief Operating Officer
Demetrios G. Demetriades Secretary and Independent Director
Prof. Dimitrios Trafalis Head of Oncology

Latest SEC Filings

Date Type Title
Nov 17, 2025 8-K Current Report
Nov 14, 2025 10-Q Quarterly Report
Nov 7, 2025 S-3 Registration statement under Securities Act of 1933
Oct 17, 2025 8-K Current Report
Oct 6, 2025 8-K Current Report
Oct 1, 2025 8-K Current Report
Sep 29, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Sep 29, 2025 8-K Current Report
Sep 23, 2025 S-3/A [Amend] Registration statement under Securities Act of 1933
Sep 19, 2025 424B3 Prospectus